FDA Investigator: Michelle Y. Clark Stuart
- Michelle Y. Clark Stuart first started conducting FDA inspections in 2004, with the last inspection in 2012. Over that time, Michelle Y. Clark Stuart has conducted 17 inspections at 14 companies across 15 sites.
Get Michelle Clark Stuart's official FDA inspection documents. Gain valuable insights from their Form 483s and EIRs to ace your next inspection.
Documents
Upon purchase, you will receive an email with a link to immediately download the documents.
FDA 483 DSM Pharmaceuticals Inc, Greenville | 2012
Out-of-stock
Michelle Y. Clark Stuart
Human Drug Form 483
FDA 483 Genzyme A Sanofi Company, Lynnwood | 2011
Out-of-stock
Michelle Y. Clark Stuart
Human Drug Form 483
FDA 483 Lonza Biologics, Inc., Portsmouth | 2010
Out-of-stock
Michelle Y. Clark Stuart
Human Drug Form 483
FDA 483 Bristol-Myers Squibb Co., Pharmaceutical Research Institute, East Syracuse | 2009
Out-of-stock
Michelle Y. Clark Stuart
Human Drug Form 483
FDA 483 Boehringer Ingelheim Pharma Gmbh & Co Kg, Biberach An Der Riss | 2008
Out-of-stock
Michelle Y. Clark Stuart
Human Drug Form 483
FDA 483 Regeneron Pharmaceuticals Inc, Rensselaer | 2007
Out-of-stock
Michelle Y. Clark Stuart
Human Drug Form 483
FDA 483 Boehringer Ingelheim Fremont, Inc., Fremont | 2006
Out-of-stock
Michelle Y. Clark Stuart
Human Drug Form 483
FDA 483 Amgen Manufacturing Limited, Inc., Juncos | 2005
Out-of-stock
Michelle Y. Clark Stuart
Human Drug Form 483
Co-Investigators (12)
- Donald C. Obenhuber, FDA Investigator
- Clark Stuart, Michelle Y, FDA Investigator
- Min Tang, FDA Investigator
- Steven Fong, FDA Investigator
- Sunitha K. Rajaram, FDA Investigator
- Barbara J. Breithaupt, FDA Investigator
- Maria P. Kelly-Doggett, FDA Investigator
- Bo Chi, FDA Investigator
- Jianming Li, FDA Investigator
- Calvin Koerner, FDA Investigator
- Rebecca Parrilla, FDA Investigator
- Ann L. Demarco, FDA Investigator